Hodgkin lymphoma among patients infected with HIV in post-HAART era

Clinical Lymphoma and Myeloma

Volumn 7, Issue 5, 2007, Pages 364-368

  Tanaka, Paula Yurie ^a,b   Pessoa Jr , Vicente Porfírio ^a   Pracchia, Luis Fernando ^c   Buccheri, Valeria ^c   Chamone, Dalton Alencar Fisher ^c   Calore, Edenilson Eduardo ^a  

^a INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^b Centro de Referencia e Treinamento em DST AIDS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

AIDS; CD4 cell count; Complete remission; Granulocyte colony stimulating factor

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; EFAVIRENZ; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; PROCARBAZINE; PROTEINASE INHIBITOR; RECOMBINANT ERYTHROPOIETIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; VINBLASTINE; VINCRISTINE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANCER REGRESSION; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PNEUMOCYSTIS PNEUMONIA; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT RESPONSE;

EID: 34248198014     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2007.n.014     Document Type: Article

References (12)

1. Franceschi S, Dal Maso L, Arniani S, et al. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer 1998; 7:966-970.
2. Engels EA, Goedert JJ. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future. J Natl Cancer Inst 2005; 6:407-409.
3. Lim ST, Levine AM. Recent advances in acquired immunodeficiency syndrome (AIDS)-related lymphoma. CA Cancer J Clin 2005; 4:229-241.
4. Dolcetti R, Boiocchi M, Gloghini A, et al. Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease. Eur J Cancer 2001; 10:1276-1287.
5. Errante D, Tirelli U, Gastaldi R, et al. Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT). Cancer 1994; 2:437-444.
6. Levine AM, Li P, Cheung T, et al. Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). J Acquir Immune Defic Syndr 2000; 5:444-450.
7. Tirelli U, Errante D, Dolcetti R, et al. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 1995; 7:1758-1767.
8. Rubio R. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid. Cancer 1994; 9:2400-2407.
9. Vaccher E, Spina M, Tirelli U. Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals. Eur J Cancer 2001; 10:1306-1315.
10. Hoffmann C, Chow KU, Wolf E, et al. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol 2004; 4:455-462.
11. Spina M, Gabarre J, Rossi G, et al. Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood 2002; 6:1984-1988.
12. Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood 2006; 108:3786-3791.